10:51 AM
Nov 13, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Alzheimer’s disease (AD)

Cell culture and mouse studies suggest inhibiting HDAC3 could help treat AD. In a HEK cell line expressing mutant APP, a tool compound HDAC3 inhibitor decreased levels of neurotoxic...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >